Geneva, 26 April 2023 – Millions of children living in some of the world’s hardest-to-reach communities are to get access to essential vaccines for the first time, thanks to funding from Gavi, the Vaccine Alliance’s Zero-Dose Immunization Programme (ZIP).
The push to reach ‘zero-dose’ children – those who have not received a single routine vaccine shot – is focused on two regions, the Horn of Africa and the Sahel and specifically in areas where children have traditionally been hard to reach through government programmes. For the first time, the Gavi funding is being channelled through two international civil society organizations, the International Rescue Committee (IRC) and World Vision (the Sahel) which will in turn build the local partnerships and tailored approaches suitable for their respective regions.
“With millions of children systemically missing out on routine vaccines every year, these targeted investments will help us reach some of the hardest-to-reach children,” said Thabani Maphosa, Managing Director of Country Programmes Delivery at Gavi. “The Zero-Dose Immunization Programme is taking on our toughest challenges, working with new partners and new innovations to access communities in humanitarian settings.”
The funding will support a number of projects and pilot programmes – and will also go towards the implementation of a learning agenda to identify and develop the best methods and practices to reach children living in fragile, conflict and cross-border settings.
“Through the generous funding by Gavi, the Vaccine Alliance, the International Rescue Committee (IRC) lead for Reaching Every Child in Humanitarian Setting (REACH) Consortia has rolled-out immunisation services in conflict, fragile, and cross-border settings in the Horn of Africa,” said Shife Demissie, Project Director of the Gavi REACH program, International Rescue Committee. “Already, 65,000 zero-dose and under-immunised children have received diphtheria, pertussis, tetanus-containing vaccine (DTP) and over 160,000 children receiving the measles-containing vaccine (MCV).
“The IRC is applying innovative approaches in these settings including optimising immunisation service points and context-tailored delivery approaches to increase access. These include the use of geo-spatial mapping, population data, and IOM’s Displacement Tracking Matrix; combining immunisation with key health and socio-economic services; negotiating humanitarian access for immunisation service provision; and utilising civil society-led models for effective, inclusive vaccination programs.”
“World Vision has extensive experience providing immunization services to communities in humanitarian and fragile settings and plans to reach – through this project – children in hard-to-reach areas characterized by chronic armed conflict, climatic shocks, and mobile populations (IDPs, refugees, nomads),” said Chief of Party for Raise4Sahel, Dr Enrique Paz. “World Vision’s approach to reaching zero-dose children include implementing emergency vaccination strategies, utilizing novel logistics equipment, and integrating Nutrition, WASH, Gender, Interfaith, and demand generation approaches. Led by World Vision, the Raise 4 Sahel Consortium partners will contribute their expertise to support innovative approaches to reaching zero-dose and under-immunized children.”
Earlier this week, the World Health Organization (WHO), UNICEF, Gavi and The Bill & Melinda Gates Foundation, along with other global and national health partners, announced ‘The Big Catch-up’, a targeted global effort to boost vaccination among children following a decline in vaccination coverage driven by the COVID-19 pandemic. ZIP will complement these efforts by targeting children that live outside of government reach and who continually miss out on immunisation.
The International Rescue Committee is working closely with Flowminder, IOM, ThinkPlace, and various local organizations and CSOs in Ethiopia, Somalia, South Sudan, and Sudan. World Vision is collaborating with the Africa Christian Health Association (ACHAP), Cameroon Baptist Convention Health Services (CBCHS), Association Evangelique pour la Sante au Tchad (AEST), Christian Health Association of Nigeria (Chan), Food for the Hungry, Dimagi and Core Group alongside local partners, reaching 93 districts across Chad, Niger, Nigeria, CAR, Cameroon, Mali and Burkina Faso.
Gavi disbursed US$ 9 million in 2022 to fund the inception phase of ZIP and this week is disbursing an additional US$ 28 million. The US$ 37 million funding is part of a total of US$ 100 million that Gavi has committed to the Zero-Dose Immunization Programme (ZIP). ZIP falls under Gavi’s US$ 500 million Equity Accelerator Fund, dedicated to reducing the zero-dose burden in lower-income countries by investing in targeted initiatives. The remaining US $400 million is currently being channelled to Gavi-implementing countries to sustainably reach zero-dose children with a full range of vaccines through national immunisation programmes.
Reaching zero-dose children and improving routine immunisation coverage in underserved communities is critical as it can often be the first step towards comprehensive primary healthcare, allowing the most vulnerable populations to access essential health services.
Notes to editors
About Gavi, the Vaccine Alliance
Gavi, the Vaccine Alliance is a public-private partnership that helps vaccinate half the world’s children against some of the world’s deadliest diseases. Since its inception in 2000, Gavi has helped to immunise a whole generation – over 981 million children – and prevented more than 16.2 million future deaths, helping to halve child mortality in 73 lower-income countries. Gavi also plays a key role in improving global health security by supporting health systems as well as funding global stockpiles for Ebola, cholera, meningococcal and yellow fever vaccines. After two decades of progress, Gavi is now focused on protecting the next generation, above all the zero-dose children who have not received even a single vaccine shot. The Vaccine Alliance employs innovative finance and the latest technology – from drones to biometrics – to save millions more lives, prevent outbreaks before they can spread and help countries on the road to self-sufficiency. Learn more at www.gavi.org and connect with us on Facebook and Twitter.
Gavi is a co-convener of COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator, together with the Coalition for Epidemic Preparedness Innovations (CEPI), the World Health Organization (WHO) and UNICEF. In its role, Gavi is focused on procurement and delivery for COVAX: coordinating the design, implementation and administration of the COVAX Facility and the Gavi COVAX AMC and working with its Alliance partners UNICEF and WHO, along with governments, on country readiness and delivery.
The Vaccine Alliance brings together developing countries and donor governments, the World Health Organization, UNICEF, the World Bank, the vaccine industry, technical agencies, civil society, the Bill & Melinda Gates Foundation and other private sector partners. View the full list of donor governments and other leading organisations that fund Gavi’s work here.
Article first published on
By Lusayo Banda, Communications Manager-Amref Health Africa Malawi For over a decade, Paul Chakamba has…
Authors: Desta Lakew, Group Director, Partnerships and External Affairs, Amref Health Africa; and Alvin Tofler Munyasia,…
On the sidelines of the 2024 UN Climate Conference (COP29), Amref Health Africa and the…
Global warming is no longer just an issue for the environment but a crisis of…
What is COP 29 and why is it important? COP (Conference of the Parties) is…
Co-Chairs publish draft text for the New Collective Quantified Goal (NCQG), described as workable basis…